Zenas BioPharma, Inc.
ZBIO
$34.50
-$2.57-6.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 290.88M | 273.28M | 312.38M | 350.77M | 386.80M |
| Total Receivables | 1.30M | 1.30M | 1.70M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.46M | 4.02M | 3.73M | 3.07M | 6.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 2.09M | -- |
| Total Current Assets | 296.64M | 278.60M | 317.81M | 355.92M | 393.78M |
|
|
|||||
| Total Current Assets | 296.64M | 278.60M | 317.81M | 355.92M | 393.78M |
| Net Property, Plant & Equipment | 857.00K | 1.07M | 1.28M | 1.19M | 545.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.80M | 11.80M | 12.85M | 12.86M | 9.11M |
| Total Assets | 322.02M | 293.09M | 333.77M | 369.97M | 403.43M |
|
|
|||||
| Total Accounts Payable | 6.44M | 7.93M | 20.02M | 17.14M | 15.08M |
| Total Accrued Expenses | 45.36M | 44.52M | 28.20M | 39.16M | 28.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 618.00K | 793.00K | 908.00K | 785.00K | 384.00K |
| Total Finance Division Other Current Liabilities | -- | -- | 5.00K | 211.00K | -- |
| Total Other Current Liabilities | -- | -- | 5.00K | 211.00K | -- |
| Total Current Liabilities | 52.42M | 53.24M | 49.13M | 57.29M | 44.00M |
|
|
|||||
| Total Current Liabilities | 52.42M | 53.24M | 49.13M | 57.29M | 44.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 180.00K | 215.00K | 317.00K | 218.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.99M | -- | -- | -- | -- |
| Total Liabilities | 125.59M | 53.46M | 49.45M | 57.51M | 44.00M |
|
|
|||||
| Common Stock & APIC | 721.18M | 712.91M | 705.14M | 699.66M | 694.17M |
| Retained Earnings | -524.69M | -473.19M | -420.96M | -387.39M | -334.79M |
| Treasury Stock & Other | -69.00K | -94.00K | 141.00K | 194.00K | 54.00K |
| Total Common Equity | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M |
|
|
|||||